week 1 Flashcards
Cmax
maximum (peak) plasma drug conc
Tmax
time to reach Cmax
when taking a drug you may go above minimum effective concentration
MEC. you get desired effect. eventually it will fall below the MEC. pharmacological benefit is gone, but some drug may still be there.
minimum effective concentration for adverse reactions
drug acts on specific targets that are beneficial in some parts of the body and dangerous in others
after multiple doses of a drug
The amount of drug administered exactly replaces the amount of drug eliminated. When this occurs the drug is said to be at steady state. show same peak every single time they take the dose. they dont have any remaining from previous dose. need 4-5 half lives to achieve steady state.
steady state concentration, Css
Average concentration of steady state
once absorption occurs,
the free drug has been able to pass into the plasma where it may encounter proteins to which it may bind or unbind in the blood. Sometimes these proteins have the ability to carry the drugs, sometimes they do not.
unbound
drug can diffuse across other cell membranes and get through barriers and enter diff tissues more readily. has to interact with some sort of receptor.
one of the receptors may help to drive pharmacological benefit/efficacious benefit
another receptor may drive an undesirable side effect (toxicity)
distribution
the drug will flow into diff tissues. The free drug may bind or unbind to diff factors in that tissue compartment.
how fast can the body remove the active drug from circulation?
metabolism- drug remains in body but converted to another form
excretion - filtered in kidneys or excreted in bile and removed from body through poopies
biopharmaceuticals
– Examines properties of the drug, dosage form, and route of administration on the rate and extent of systemic drug absorption
• stability
• release
• rate of dissolution
• systemic absorption
Goal
– develop drug products with optimal and predictable drug absorption characteristics
pharmacokinetics
– science of quantifying the amount and time course of a drug within the body
– characterization of absorption, distribution, metabolism, excretion (ADME)
– “What the body does to the drug”
•Goal
– control the amount of drug exposure at the site of drug action (effect)
pharmacodynamics
– the relationship between drug concentration at the site of activity (receptor) and effects (i.e. intensity and time course) including both efficacy and toxic
– “What the drug does to the body”
Goal
– control drug response by understanding the concentration effect relationship and establishing appropriate therapeutic targets
important PD parameters
onset of action
mainly determined by rate of drug absorption, i.e. rapid absorption produces a short onset
important PD parameters
duration of action
determined by rate of drug elimination, therefore drug with a short half-life may have a short duration of action
important PD parameters
intensity (magnitude) of effect
often proportional to plasma drug concentration, i.e., Cmax and AUC
the pharmacodynamic, for a desirable output is related to
the plasma concentration of the drug
phenytoin
people with a lot of variability. extreme differences in pharmacokinetics bw patients. therapeutic drug monitoring is required
experimental methods
• drug concentrations in biological samples are determined by analytical methods
assays need to be
– sensitive- measure drug at low concentrations
– specific- distinguish drug from other interference
– precise- provide accuracy and reproducibility
PK depends on sample measured
• drugs act on targets in tissues
• as a proxy for tissue concentration the following may be used
– plasma - whole blood has been obtained in the prescence of something that inhibits clotting. typically heparin, or edta
– serum (-clotting factors) - (allows blood to clot and then centrifuge it, removes RBC and WBC and clotting factors and any drug that is bound to the clotting factors)
– whole blood (RBCs, WBCs)
• drug in blood samples may be free or bound to proteins
what are the applications for PK?
- design dosage regimen (how much, how often) that maximizes therapy while minimizes side effects
- clarifies the relationship bw therapeutic and toxic responses at different regimens
- adjust drug dosage regimen using therapeutic drug monitoring (TDM)
- “Population Pharmacokinetics”
- establish bioequivalence i.e., to check whether different formulations will produce the same plasma drug concentrations or not, and therefore will produce similar therapeutic effects
semi graph log paper
you never go to zero (y axis). get a ruler and there should be points above and below the line.
digoxin once daily administration suffices
stable, little lost each day. morphine is eliminated very rapidly from the body, given more frequently.